Mifepristone and misoprostol compared with misoprostol alone for second-trimester abortion: A randomized controlled trial

Obstetrics and Gynecology

Volumn 118, Issue 3, 2011, Pages 601-608

  Ngoc, Nguyen Thi Nhu ^a,b,c   Shochet, Tara ^a,b,c   Raghavan, Sheila ^a,b,c   Blum, Jennifer ^a,b,c   Nga, Nguyen Thi Bach ^a,b,c   Minh, Nguyen Thi Hong ^a,b,c   Phan, Van Quy ^a,b,c   Winikoff, Beverly ^a,b,c  

^a Hung Vuong Hospital   (Viet Nam)

^b GYNUITY HEALTH PROJECTS   (United States)

^c Vietnam National Ob Gyn Hospital   (Viet Nam)

Author keywords

[No Author keywords available]

Indexed keywords

MIFEPRISTONE; MISOPROSTOL;

ADOLESCENT; ADULT; ARTICLE; CHILL; CONTROLLED STUDY; DIARRHEA; DILATION AND EVACUATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GESTATIONAL AGE; HEADACHE; HUMAN; MEDICAL ABORTION; NAUSEA AND VOMITING; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SECOND TRIMESTER ABORTION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VIET NAM;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTIFACIENT AGENTS, STEROIDAL; ABORTION, INDUCED; ADMINISTRATION, BUCCAL; ADOLESCENT; ADULT; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MIFEPRISTONE; MISOPROSTOL; PAIN MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, SECOND; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80052137827     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e318227214e     Document Type: Article

References (28)

1. World Health Organization. Safe abortion: technical and policy guidance for health systems. Geneva (Switzerland): World Health Organization; 2003.
2. Tang OS, Ho PC. Medical abortion in the second trimester. Best Pract Res Clin Obstet Gynaecol 2002;16:237-246. (Pubitemid 41123418)
3. United Nations Development Program/United Nations Fund for Population Activities/World Health Organization/World Bank Special Programme of Research Development and Research Training in Human Reproduction. Annual technical report. 1997. Geneva (Switzerland): World Health Organization; 1998.
4. Hamoda H, Ashok PW, Flett GM, Templeton A. Medical abortion at 9-13 weeks' gestation: a review of 1076 consecutive cases. Contraception 2005;71:327-332. (Pubitemid 40602308)
5. Goh SE, Thong KJ. Induction of second trimester abortion (12-20 weeks) with mifepristone and misoprostol: a review of 386 consecutive cases. Contraception 2006;73:516-519.
6. Bartley J, Baird DT. A randomised study of misoprostol and gemeprost in combination with mifepristone for induction of abortion in the second trimester of pregnancy. BJOG 2002; 109:1290-294. (Pubitemid 36164757)
7. el-Refaey H, Hinshaw K, Templeton A. The abortifacient effect of misoprostol in the second trimester: a randomized comparison with gemeprost in patients pre-treated with mifepristone (RU486). Hum Reprod 1993;8:1744-746. (Pubitemid 23299803)
8. Clark W, Shannon C, Winikoff B. Misoprostol for uterine evacuation in induced abortion and pregnancy failure. Expert Rev Obstet Gynecol 2007;2:67-108.
9. Eng NS, Guan AC. Comparative study of intravaginal misoprostol with gemeprost as an abortifacient in second trimester missed abortion. Aust N Z J Obstet Gynaeco. 1997;37:331-334. (Pubitemid 27361951)
10. Wong KS, Ngai CS, Wong AY, Tang LC, Ho PC. Vaginal misoprostol compared with vaginal gemeprost in termination of second trimester pregnancy. A randomized trial. Contraception 1998;58:207-210. (Pubitemid 28565180)
11. Nuutila M, Toivonen J, Ylikorkala O, Halmesmaki E. A comparison between two doses of intravaginal misoprostol and gemeprost for induction of second-trimester abortion. Obstet Gynecol 1997;90:896-900. (Pubitemid 27510125)
12. Wong KS, Ngai CS, Chan KS, Tang LC, Ho PC. Termination of second trimester pregnancy with gemeprost and misoprostol: a randomized double-blind placebo-controlled trial. Contraception 1996;54:23-5. (Pubitemid 26230797)
13. Ashok PW, Templeton A. Nonsurgical mid-trimester termination of pregnancy: a review of 500 consecutive cases. Br J Obstet Gynaecol 1999;106:706-710. (Pubitemid 29304394)
14. Royal College of Obstetricians and Gynaecologists. The care of women requesting induced abortion: evidence-based clini-cal guideline No. 7. London (UK): Royal College of Obstetricians and Gynaecologists; 2004.
15. Ho PC, Blumenthal PD, Gemzell-Danielsson K, Gómez Ponce de León R, Mittal S, Tang OS. Misoprostol for the termination of pregnancy with a live fetus at 13 to 26 weeks. Int J Gynaecol Obstet 2007;99(suppl 2):S178-181. (Pubitemid 350101543)
16. Ngoc NT, Nhan VQ, Blum J, Mai TT, Durocher JM, Winikoff B. Is home-based administration of prostaglandin safe and feasible for medical abortion? Results from a multisite study in Vietnam. BJOG 2004;111:814-819. (Pubitemid 39061504)
17. Hajri S, Blum J, Gueddana N, Saadi H, Maazoun L, Ché lli H, et al. Expanding medical abortion in Tunisia: women's experiences from a multi-site expansion study. Contraception 2004; 70:487-491. (Pubitemid 39488206)
18. Schaff EA, Fielding SL, Westhoff C, Ellertson C, Eisinger SH, Stadalius LS, et al. Vaginal misoprostol administered 1, 2, or 3 days after mifepristone for early medical abortion: a randomized trial. JAMA 2000;284:1948-953.
19. Creinin MD, Fox MC, Teal S, Chen A, Schaff EA, Meyn LA; MOD Study Trial Group. A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion. Obstet Gynecol 2004;103:851-859. (Pubitemid 40458983)
20. Shannon C, Wiebe E, Jacot F, Guilbert E, Dunn S, Sheldon WR, et al. Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial. BJOG 2006;113:621-628. (Pubitemid 43781692)
21. von Hertzen H, Piaggio G, Wojdyla D, Nguyen TM, Marions L, Okoev G, et al. Comparison of vaginal and sublingual misoprostol for second trimester abortion: randomized controlled equivalence trial. Hum Reprod 2009; 24:106-112.
22. Kapp N, Borgatta L, Stubblefield P, Vragovic O, Moreno N. Mifepristone in second-trimester medical abortion: a randomized controlled trial. Obstet Gynecol 2007;110:1304-310. (Pubitemid 351326074)
23. Dickinson JE, Brownell P, McGinnis K, Nathan EA. Mifepristone and second trimester pregnancy termination for fetal abnormality in Western Australia: worth the effort. Aust N Z J Obstet Gyneacol 2010;50:60-4.
24. Fjerstad M, Trussell J, Sivin I, Lichtenberg ES, Cullins V. Rates of serious infection after changes in regimens for medical abortion. N Engl J Med 2009;361:145-151.
25. Meckstroth KR, Whitaker AK, Bertisch S, Goldberg AB, Darney PD. Misoprostol administered by epithelial routes: drug absorption and uterine response. Obstet Gynecol 2006; 108:582-590. (Pubitemid 44337099)
26. Winikoff B, Dzuba IG, Creinin MD, Crowden WA, Goldberg AB, Gonzales J, et al. Two distinct oral routes of misoprostol in mifepristone medical abortion: a randomized controlled trial. Obstet Gynecol 2008;112:1303-310.
27. Ruano R, Dumez Y, Cabrol D, Dommergues M. Second-and third-trimester therapeutic terminations of pregnancy in cases with complete placenta previa-does feticide decrease postdelivery maternal hemorrhage? Fetal Diagn Ther 2004;19: 475-478. (Pubitemid 39482641)
28. Borgatta L, Kapp N. Labor induction abortion in the second trimester. Contraception 2011 Mar 11 [Epub ahead of print].